Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
A. Deckert and
et al,
"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial",
Trials,
vol. 22,
no. 1,
2021.
| DOI: | 10.1186/s13063-020-04982-z |
A. Deckert and
D. Stahl,
"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling",
Trials,
vol. 22,
no. 1,
2021.
| DOI: | 10.1186/s13063-021-05619-5 |
| Datei: | https://doi.org/10.1186/s13063-021-05619-5 |
A. Deckert,
M. De Allegri and
et al,
"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling",
Trials,
vol. 22,
no. 1,
2021.
| DOI: | 10.1186/s13063-021-05619-5 |
P. Beschoner,
M. Jarczok,
M. Kempf,
K. Weimer,
F. Geiser,
N. Hiebel,
Y. Erim,
E. Morawa,
S. Steudte-Schmiedgen and
L. Jerg-Bretzke,
"egePan-VOICE study on the psychosocial burden of the Covid-19 pandemic among medical technical assistants",
Z Psychosom Med Psychother,
2021.
M. Kahn,
S. Zellmer,
A. Ebigbo and
et al,
"Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland",
Z Gastroenterol,
vol. 59,
no. 12,
2021.
| DOI: | 10.1055/a-1649-8184 |
S. Zellmer,
M. Kahn,
A. Ebigbo and
et al,
"Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland",
Z Gastroenterol,
vol. 59,
no. 8,
2021.
| DOI: | 10.1055/s-0041-1734140 |
B. Jensen,
N. Luebke,
T. Feldt and
et al,
"Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany",
Lancet Reg Health Eur,
vol. 8,
2021.
| DOI: | 10.1016/j.lanepe.2021.100164 |
B. Jensen,
N. Luebke,
T. Feldt,
V. Keitel,
T. Brandenburger,
D. Kindgen-Milles,
M. Lutterbeck,
N. Freise,
D. Schoeler,
R. Haas,
A. Dilthey,
A. Walker,
J. Timm and
T. Luedde,
"Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany",
The Lancet regional health. Europe,
vol. 8,
pp. 100164,
2021.
| DOI: | 10.1016/j.lanepe.2021.100164 |
B. Jensen,
N. Luebke,
T. Feldt,
V. Keitel,
T. Brandenburger,
D. Kindgen-Milles,
M. Lutterbeck,
N. F. Freise,
D. Schoeler,
R. Haas,
A. Dilthey,
O. Adams,
A. Walker,
J. Timm and
T. Luedde,
"Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany",
The Lancet Regional Health- Europe,
2021.
| DOI: | 10.1016/j.lanepe.2021.100164 |
| Datei: | https://doi.org/10.1016/j.lanepe.2021.100164 |
L. Ruhl and
et al,
"Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks",
Signal transduction and targeted therapy,
vol. 6,
pp. 418,
2021.
| DOI: | 10.1038/s41392-021-00819-6 |
[German]
S. Stillfried,
P. Boor and
D. PANDEMIcs,
"Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin",
Pathologe,
pp. 1-5,
2021.
| DOI: | 10.1007/s00292-021-01004-w |
F. Zack,
S. Nigbur,
J. Manhart,
H. Derani,
D. Boy,
V. Kolbe and
A. Büttner,
"Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock",
Ärztebl Meckl-Vorpom,
vol. 31,
pp. 125-128,
2021.
[German]
F. Zack,
S. Nigbur,
H. Derani,
D. Boy,
A. Port and
A. Büttner,
"Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock",
Ärzteblatt Mecklenburg-Vorpommern,
vol. 31,
pp. 125—128,
2021.
| Datei: |  https://aerzteblatt-mvp.de/pdf/mv2104_125.pdf |
A. Revet,
J. Hebebrand,
L. Kehoe,
C. Child,
S. Bender and
P. Klauser,
"ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services",
European Child & Adolescent Psychiatry,
2021.
| DOI: | 10.1007/s00787-020-01699-x |
R. Wagner,
D. Peterhoff,
S. Beileke and
et al,
"Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: The population-based Tirschenreuth study in the hardest-hit German county in spring 2020",
Viruses,
vol. 13,
no. 6,
2021.
| DOI: | 10.3390/v13061118 |
| Datei: | https://doi.org/10.3390/v13061118 |
T. C. Jones and
et al,
"Estimating infectiousness throughout SARS-CoV-2 infection course",
Science (New York, N.Y.),
2021.
| DOI: | 10.1126/science.abi5273 |
K. A. Eberhardt and
et al,
"Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG",
Microorganisms,
vol. 9,
2021.
| DOI: | 10.3390/microorganisms9040733 |
M. Korenkov,
N. Poopalasingam,
M. Madler and
et al,
"Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals",
J Clin Microbiol,
vol. 59,
no. 9,
2021.
| DOI: | 10.1128/JCM.00896-21 |
T. Toptana,
L. Eckermann,
A. E. Pfeiffer and
et al,
"Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?",
J Clin Virol,
vol. 135,
2021.
| DOI: | 10.1016/j.jcv.2020.104713 |
J. Hildebrandt,
M. I. Metzendorf and
T. Jakob,
"Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister",
GMS Med Inform Biom Epidemiol,
vol. 17,
no. 3,
pp. Doc12,
2021.
| DOI: | 10.3205/mibe000226 |
| Datei: |
M. Popp,
P. Kranke,
P. Meybohm,
M. Metzendorf,
N. Skoetz,
M. S. Stegemann and
S. Weibel,
"Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges",
BMJ Evid Based Med,
vol. 2021,
pp. bmjebm-2021-111791,
2021.
| DOI: | 10.1136/bmjebm-2021-111791 |
J. Wachinger,
M. Schirmer,
N. Täuber and
et al,
"Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study",
BMJ Paediatr Open,
vol. 5,
no. 1,
2021.
| DOI: | 10.1136/bmjpo-2021-001262 |
| Datei: | https://doi.org/10.1136/bmjpo-2021-001262 |
J. M. Tielker,
J. Weber,
S. T. Simon,
C. Bausewein,
S. Stiel and
N. Schneider,
"Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany",
PLoS ONE,
vol. 16,
no. 7,
pp. e0254056,
2021.
| DOI: | 10.1371/journal.pone.0254056 |
[Deutsch]
P. Michel,
G. Savinsky,
B. Ondruschka and
I. Czinczoll,
"Folgen einer Reanimation in Zeiten der Pandemie",
Hamburger Ärzteblatt,
vol. 2021,
no. 11,
pp. 28—30,
2021.
| Datei: | https://fis-uke.de/portal/de/publications/folgen-einer-reanimation-in-zeiten-der-pandemie(943a98ca-7e65-4bc3-abeb-f520157640a7).html |
M. Muenchhoff,
A. Graf,
S. Krebs and
et al,
"Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020",
Euro Surveill,
vol. 26,
no. 43,
2021.
| DOI: | 10.2807/1560-7917.ES.2021.26.43.2002066 |
| Datei: | https://doi.org/10.2807/1560-7917.ES.2021.26.43.2002066 |
S. Thun,
J. Sass and
A. Bartschke,
"German Corona Consensus Datensatz (GECCO): Verbesserter Austausch von COVID-19-Forschungsdaten",
kma - Klinik Management aktuell,
vol. 26,
no. 06,
pp. 55—56,
2021.
| DOI: | 10.1055/s-0041-1731187 |
A. Gruber,
T. Firsching,
J. Trimpert and
K. Dietert,
"Hamster models of COVID-19 pneumonia reviewed: How human can they be?",
Vet Pathol,
2021.
M. Schmidt,
S. Kugai and
B. Weltermann,
"Handlungsfähigkeit von Hausärzt*innen während der COVID-19-Pandemie",
DocV-15-05,
2021.
| DOI: | 10.3205/21degam086 |
J. A. F. Klein,
L. J. Krüger,
F. Tobian and
et al,
"Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test",
Med Microbiol Immunol,
vol. 210,
no. 4,
2021.
| DOI: | 10.1007/s00430-021-00710-9 |
| Datei: | https://doi.org/10.1007/s00430-021-00710-9 |
S. Hadzibegovic,
A. Lena,
T. Churchill,
J. Ho,
S. Potthoff,
C. Denecke,
L. Rösnick,
K. Heim,
M. Kleinschmidt,
L. Sander and
D. Stahl,
"Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings",
Eur J Heart Fail,
vol. 23,
no. 11,
pp. 1891—1902,
2021.
| DOI: | 10.1002/ejhf.2210 |
R. Groß and
et al,
"Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants",
EBioMedicine,
vol. 75,
pp. 103761,
2021.
| DOI: | 10.1016/j.ebiom.2021.103761 |
M. Tenbusch,
S. Schumacher,
E. Vogel and
et al,
"Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2",
Lancet Infect Dis,
vol. 21,
no. 9,
2021.
| DOI: | 10.1016/S1473-3099(21)00420-5 |
M. Rössler,
J. Jacob,
L. Risch,
F. Tesch,
D. Enders,
D. Wende,
R. Jucknewitz,
O. Weidinger,
M. Batram,
P. Ballesteros,
S. Baßler,
D. Hertle,
U. Repschläger,
N. Richter,
C. Schulte,
A. Schramm,
F. Sobik,
M. Treskova-Schwarzbach,
S. Scholz,
J. Walker and
D. Stahl,
"Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen",
2021.
| DOI: | 10.25646/8405.2 |
M. Lehmann,
C. Heldt,
J. Meinhardt,
F. Schmidt and
e. a. Rodriguez-Sillke,
"Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells",
Mucosal Immunol,
vol. 14,
pp. 1381—1392,
2021.
M. Lehmann,
C. Heldt and
et al,
"Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells",
Mucosal Immunol,
pp. 1-12,
2021.
| DOI: | 10.1038/s41385-021-00437-z |
J. Barros-Martins,
S. I. Hammerschmidt and
A. Cossmann,
"Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
MedRxiv,
2021.
| DOI: | 10.1101/2021.06.01.21258172 |
| Datei: | https://doi.org/10.1101/2021.06.01.21258172 |
S. Trump,
S. Lukassen,
S. M. Anker,
R. L. Chua,
J. Liebig and
e. a. Thurmann,
"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19",
Nat Biotechnol,
vol. 39,
pp. 705—716,
2021.
| DOI: | 10.1038/s41587-021-00937-2 |
C. Walsh,
P. Tafforeau,
W. Wagner and
et al,
"Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography",
Nat Methods,
vol. 18,
no. 12,
pp. 1532-1541,
2021.
| DOI: | 10.1038/s41592-021-01317-x |
J. Barros-Martins and
et al,
"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
Nature Medicine,
vol. 27,
pp. 1525—1529,
2021.
| DOI: | 10.1038/s41591-021-01449-9 |
D. L. Burnett and
et al,
"Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability",
Immunity,
vol. 54,
pp. 2908—2921.e6,
2021.
| DOI: | 10.1016/j.immuni.2021.10.019 |
E. Schrezenmeier and
et al,
"Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis",
Frontiers in immunology,
vol. 12,
pp. 690698,
2021.
| DOI: | 10.3389/fimmu.2021.690698 |
R. J. Neumann,
B. Kollmann,
J. Brokelmann,
N. M. Werthern,
A. Malsyhau,
D. Weichert,
B. Lutz,
C. J. Fiebach,
M. Wessa and
D. Stahl,
"Impact of COVID-19 lockdown on mental health in Germany: Longitudinal observation of different mental health trajectories and protective factors",
Translational Psychiatry,
vol. 11,
no. 1,
pp. 1—10,
2021.
| DOI: | 10.1038/s41398-021-01508-2 |
B. Mühlemann and
et al,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study",
Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
2021.
| DOI: | 10.1016/j.cmi.2021.06.008 |
B. Mühlemann,
C. Thibeault,
D. Hillus,
E. Helbig,
L. Lippert,
P. Tober-Lau,
T. Schwarz,
M. Müller,
P. group,
M. Witzenrath and
D. Stahl,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study",
Clin Microbiol Infect,
2021.
| DOI: | 10.1016/j.cmi.2021.06.008 |
B. Mühlemann,
C. Thibeault,
D. Hillus,
E. Helbig,
L. Lippert,
P. Tober-Lau,
T. Schwarz,
M. Müller,
P. group,
M. Witzenrath,
N. Suttorp,
L. E. Sander,
C. Drosten,
T. C. Jones,
V. Corman and
F. Kurth,
"Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021;27(10)",
2021.
| DOI: | 1520.e7-1520.e10 |
N. Dauletbaev,
S. Kuhn,
S. Holtz,
S. Waldmann,
L. Niekrenz,
B. S. Müller,
C. Bellinghausen,
M. Dreher,
G. G. U. Rohde and
C. Vogelmeier,
"Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol",
BMJ Open,
vol. 11,
no. 9,
pp. e053819,
2021.
| DOI: | 10.1136/bmjopen-2021-053819 |
A. Müller,
F. S. Melzow,
G. Göstemeyer,
S. Paris and
F. Schwendicke,
"Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers",
International Journal of Environmental Research and Public Health,
vol. 18,
no. 11,
pp. 5710,
2021.
| DOI: | 10.3390/ijerph18115710 |
V. Hennig and
et al,
"Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia",
Orphanet Journal of Rare Diseases,
vol. 16,
pp. 373,
2021.
| DOI: | 10.1186/s13023-021-02011-z |
J. Weiner,
P. Suwalski,
M. Holtgrewe,
A. Rakitko,
C. Thibeault,
M. Müller,
D. Patriki,
C. Quedenau,
U. Krüger,
V. Ilinsky,
E. Helbig,
L. Lippert,
P. Stubbemann,
X. Wang,
Z. Karadeniz,
J. Saccomanno,
J. Doehn,
R. Hübner,
B. Hinzmann,
S. Siemann,
V. Corman,
B. Mühlemann,
C. Drosten,
T. C. Jones,
N. Suttorp,
M. Witzenrath,
S. Hippenstiel,
C. Skurk,
P. Group,
L. E. Sander,
D. Beule,
U. Landmesser,
T. Guettouche,
F. Kurth,
B. Heidecker,
I. Popov,
J. Balnis,
A. Jaitovich,
L. Real,
J. Macías,
J. Pineda,
M. Fernandez-Fuertes,
M. Salvo,
A. Blueher,
S. Jurisic,
J. Beer,
J. Rutishauser,
B. Wiggli,
H. Schmid,
K. Danninger,
R. Binder,
R. Arjun Arkal,
G. Fragiadakis,
E. Mick,
C. Comet,
C. Calfee,
D. Erle,
C. Hendrickson,
K. Kangelaris,
M. Krummel,
P. Woodruff,
C. Langelier,
U. Venkataramani,
F. García,
J. Zyla,
T. Zemojtel,
P. Wolfgang,
T. Borodina and
S. Ripke,
"Increased risk of severe clinical course of COVID-19 in carriers of HLA-C",
04:01. EClinicalMedicine.2021;40:101099,
2021.
J. Weiner,
P. Suwalski,
M. Holtgrewe,
A. Rakitko,
C. Thibeault,
M. Müller,
D. Patriki,
C. Quedenau,
U. Krüger,
V. Ilinsky and
D. Stahl,
"Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01",
EClinicalMedicine,
2021.
| DOI: | 10.1016/j.eclinm.2021.101099 |